CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- CORRESP Other Correspondence Between Filers and SEC Staff
- 144 Insider Sale of Securities
- S-1 Offering Registration Statement
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Planned sale Chief Financial Officer sold 3,600 shares at $13.99 ($50,364)
- 4 Planned sale CEO and Chairman sold 2,444 shares at an average $14.01 ($34,237)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 14 · 277 filings